Thermo Fisher Scientific Inc. (TMO) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
TMO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TMO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 37.7% | 18.2% | 15.1% |
| 2024 | 41.3% | 17.9% | 14.8% |
| 2023 | 40.1% | 17.4% | 14.0% |
| 2022 | 42.3% | 19.0% | 15.5% |
| 2021 | 50.1% | 26.3% | 19.7% |
Download Data
Export TMO earnings history in CSV or JSON format
Free sign-in required to download data
Thermo Fisher Scientific Inc. (TMO) Earnings Overview
As of May 7, 2026, Thermo Fisher Scientific Inc. (TMO) reported trailing twelve-month net income of $6.86B, reflecting +7.3% year-over-year growth. The company earned $18.39 per diluted share over the past four quarters, with a net profit margin of 15.1%.
Looking at the long-term picture, TMO's 5-year EPS compound annual growth rate (CAGR) stands at +2.1%, reflecting modest earnings expansion. The company achieved its highest annual net income of $7.72B in fiscal 2021.
Thermo Fisher Scientific Inc. maintains industry-leading profitability with a gross margin of 37.7%, operating margin of 18.2%, and net margin of 15.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including DHR ($3.69B net income, 14.7% margin), A ($1.29B net income, 18.8% margin), WAT ($449M net income, 20.3% margin), TMO has outperformed on profitability metrics. Compare TMO vs DHR →
TMO Earnings vs Peers
Earnings metrics vs comparable public companies
TMO Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.74B | +6.3% | $8.11B | $17.74 | 15.1% | 18.2% |
| 2024 | $6.33B | +5.7% | $7.66B | $16.53 | 14.8% | 17.9% |
| 2023 | $6.00B | -13.7% | $7.45B | $15.45 | 14.0% | 17.4% |
| 2022 | $6.95B | -10.0% | $8.53B | $17.64 | 15.5% | 19.0% |
| 2021 | $7.72B | +21.2% | $10.32B | $19.46 | 19.7% | 26.3% |
| 2020 | $6.38B | +72.5% | $7.90B | $15.98 | 19.8% | 24.5% |
| 2019 | $3.70B | +25.8% | $4.26B | $9.17 | 14.5% | 16.7% |
| 2018 | $2.94B | +32.0% | $3.87B | $7.24 | 12.1% | 15.9% |
| 2017 | $2.23B | +10.1% | $3.27B | $5.59 | 10.6% | 15.6% |
| 2016 | $2.02B | +2.3% | $2.86B | $5.09 | 11.1% | 15.6% |
Full TMO Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy TMO Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See TMO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TMO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TMO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTMO — Frequently Asked Questions
Quick answers to the most common questions about buying TMO stock.
Is TMO growing earnings?
TMO EPS stands at $18.39, with +7.3% growth matching the 5-year CAGR of +2.1%. TTM net income is $6.9B. Earnings trajectory remains consistent.
What are TMO's profit margins?
Thermo Fisher Scientific Inc. net margin is +15.1%, with operating margin at +18.2%. Above-average margins indicate pricing power.
How consistent are TMO's earnings?
TMO earnings data spans 1989-2025. The current earnings trend is +7.3% YoY. Historical data enables comparison across business cycles.